Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Nature Reviews. Gastroenterology & Hepatology
|
January 18, 2022
Developing a cadre of clinician trialists in gastroenterology and hepatology
Nurulamin M Noor
Nature Reviews. Gastroenterology & Hepatology
|
August 18, 2023
Combination therapies: the next major frontier in IBD management
Nurulamin M Noor
Inflammatory Bowel Diseases
|
October 12, 2022
Revisiting Drug Development for Older Molecules in IBD
Paula Sousa, Nurulamin M Noor
Nature Reviews. Gastroenterology & Hepatology
|
June 12, 2023
Innovations to improve the efficiency of phase II IBD clinical trials
Nurulamin M Noor, Tim Raine
The Lancet. Gastroenterology & Hepatology
|
October 8, 2022
Partially randomised, patient preference trials for inflammatory bowel disease
Nurulamin M Noor, Corey Siegel
Gastroenterology
|
April 5, 2026
Primary immunodeficiencies masquerading as Inflammatory Bowel Diseases
Mariana Fonseca, Nurulamin M Noor
Inflammatory Bowel Diseases
|
June 15, 2022
The Endoscopic Healing Index in Crohn's Disease: A Serum Proteomic Biomarker for Monitoring Disease Activity
Nurulamin M Noor, James C Lee
Inflammatory Bowel Diseases
|
April 29, 2025
Not All Transmural Healing is Equal in Crohn's Disease: Magnetic Resonance Enterography and Intestinal Ultrasound for Stricture Assessment in the STRIDENT Trial
Kenneth Ernest-Suárez, Nurulamin M Noor
Inflammatory Bowel Diseases
|
October 16, 2024
Unmasking the Steroid Curtain: Reevaluating Corticosteroid Use in IBD Clinical Trials
Jeffrey A Berinstein, Nurulamin M Noor
United European Gastroenterology Journal
|
July 6, 2024
Seeing the whole picture: Inflammatory bowel disease complications and extraintestinal manifestations on cross-sectional imaging
Maria Manuela Estevinho, Nurulamin M Noor
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Nature Reviews. Gastroenterology & Hepatology
|
January 18, 2022
Developing a cadre of clinician trialists in gastroenterology and hepatology
Nurulamin M Noor
Nature Reviews. Gastroenterology & Hepatology
|
August 18, 2023
Combination therapies: the next major frontier in IBD management
Nurulamin M Noor
Inflammatory Bowel Diseases
|
October 12, 2022
Revisiting Drug Development for Older Molecules in IBD
Paula Sousa, Nurulamin M Noor
Nature Reviews. Gastroenterology & Hepatology
|
June 12, 2023
Innovations to improve the efficiency of phase II IBD clinical trials
Nurulamin M Noor, Tim Raine
The Lancet. Gastroenterology & Hepatology
|
October 8, 2022
Partially randomised, patient preference trials for inflammatory bowel disease
Nurulamin M Noor, Corey Siegel
Gastroenterology
|
April 5, 2026
Primary immunodeficiencies masquerading as Inflammatory Bowel Diseases
Mariana Fonseca, Nurulamin M Noor
Inflammatory Bowel Diseases
|
June 15, 2022
The Endoscopic Healing Index in Crohn's Disease: A Serum Proteomic Biomarker for Monitoring Disease Activity
Nurulamin M Noor, James C Lee
Inflammatory Bowel Diseases
|
April 29, 2025
Not All Transmural Healing is Equal in Crohn's Disease: Magnetic Resonance Enterography and Intestinal Ultrasound for Stricture Assessment in the STRIDENT Trial
Kenneth Ernest-Suárez, Nurulamin M Noor
Inflammatory Bowel Diseases
|
October 16, 2024
Unmasking the Steroid Curtain: Reevaluating Corticosteroid Use in IBD Clinical Trials
Jeffrey A Berinstein, Nurulamin M Noor
United European Gastroenterology Journal
|
July 6, 2024
Seeing the whole picture: Inflammatory bowel disease complications and extraintestinal manifestations on cross-sectional imaging
Maria Manuela Estevinho, Nurulamin M Noor
Page
of 8